Michael's Mission: Toward a Cure

FDA fast-tracks review of elinzanetant for hot flashes linked to breast cancer treatment. Here’s what the trial found and what patients should know.

After two relapses, CAR T-cell therapy and a stem cell transplant, William Yank is in remission. But infertility, mental health challenges and a changed sense of self followed him into survivorship.

A phase 3 trial found proton therapy did not help people with advanced liver cancer live longer than standard photon radiation therapy.

A breast surgeon explains how rebuilding the breast with a person's own tissue and new tools may boost satisfaction and cut repeat surgery.

Some patients with lymphoma show no detectable cancer by day 8 of treatment, and a lymphoma specialist explains how early testing could guide care.

Life after cancer can bring lasting physical, financial and emotional challenges, especially for young survivors navigating life after treatment.

Dr. Maurie Markman discusses how AI could support primary care doctors and specialists caring for patients with cancer while keeping physicians at the center.

A combination of Zenbexus, Darzalex and dexamethasone nearly doubled the rate of deep, MRD-negative responses in relapsed multiple myeloma.